Extracorporeal system for treatment of infectious and parasitic diseases

• US 4,381,004 A
• Filed: 01/15/1981
• Issued: 04/26/1983
• Est. Priority Date: 01/15/1981
• Status: Expired due to Fees

• Current Assignee: Automedix Sciences, Inc. (ICF Corp.)
• Original Assignee: Biomedica Incorporated
• Inventors: Babb, Albert L.
• Primary Examiner(s): Truluck, Dalton L.
• Application Number:
  US06/225,309
• Time in Patent Office: 831 Days
• Field of Search: 128/214 R, 128/214 B, 128/214.2, 128/DIG. 3, 210/434, 210/438, 210/638, 210/646, 210/651, 210/927
• US Class Current: 604/5.02
• CPC Class Codes: A61M 1/3687 Chemical treatment A61M1/3675 takes precedence
• CPC Class Codes: Y10S 128/03 Heart-lung

Abstract

An extracorporeal method is provided for the treatment of a disease caused by pathogenic microorganisms in the bloodstream in which blood is withdrawn from a patient and at least a fraction thereof is treated with a microorganism inactivator. Then, the inactivator and any endotoxins that may be present are removed from the blood or blood fraction, and the treated blood is returned to the patient. The method may also be used to prevent the transmission of pathogenic organisms from a blood donor to a transfusion recipient.

Claims

1. The method of treating or preventing a disease caused by microorganisms in the bloodstream comprising withdrawing blood from a bloodstream, treating at least a fraction of the withdrawn blood extracorporeally with a microorganism inactivator, and thereafter introducing at least a fraction of said blood, having a reduced microorganism level, into a bloodstream, said introduced blood or blood fraction being substantially free of said microorganism inactivator.

2. The method of claim 1 wherein said first named bloodstream is the same as said second named bloodstream and is the bloodstream of a patient afflicted with said disease.

3. The method of claim 1 wherein said first named bloodstream is the bloodstream of a blood donor and said second named bloodstream is the bloodstream of a transfusion recipient.

4. The method of treating a disease caused by microorganisms in the bloodstream comprising withdrawing blood from a patient, treating at least a fraction of the withdrawn blood extracorporeally with a microorganism inactivator, and thereafter returning said blood, having a reduced microorganism level, to said patient, said returning blood being substantially free of said microorganism inactivator.

5. The method of claim 4 wherein said microorganism inactivator is added to said blood or blood fraction in an aqueous medium and wherein substantially all of said microorganism inactivator is removed from said blood before said blood is returned to said patient.

6. The method of claim 5 wherein said microorganism inactivator is removed from said blood or blood fraction by dialysis.

7. The method of claim 6 wherein said blood or blood fraction is monitored by induced fluorescence to determine the level of microorganism inactivator therein after said dialysis.

8. The method of claim 4 wherein said microorganism inactivator is attached to an immovable carrier and said blood or blood fraction moves past said carrier.

9. The method of claim 8 wherein said immovable carrier comprises an inner wall of a conduit through which said blood or blood fraction is passed.

10. The method of claim 8 wherein said immovable carrier comprises a packing material in a packed column through which said blood or blood fraction is passed.

11. The method of claim 8 wherein said immovable carrier comprises an assembly of spaced parallel plates.

12. The method of claim 8 wherein said immovable carrier comprises a strand contained in the tubing of a bioreactor.

13. The method of claim 4 wherein whole blood is treated with said microorganism inactivator.

14. The method of claim 4 wherein said blood withdrawn from said patient is separated into a red cell fraction and a plasma fraction, wherein said plasma fraction is treated with said microorganism inactivator and wherein said red cell fraction and said treated plasma fraction are recombined before being returned to said patient.

15. The method of claim 4 wherein said disease is a bacterial infection and said microorganism inactivator comprises an antibiotic.

16. The method of claim 4 wherein said disease is a viral infection accompanied by viremia and said microorganism inactivator comprises an antiviral agent.

17. The method of claim 4 wherein said disease is a protozoal infection and said microorganism inactivator comprises an agent effective intracorporeally for the treatment of said disease.